Még nem toboroz
Exercise Therapy for Women With ANOCA
NCT07733986· NHS Greater Glasgow and Clyde· Forrás
Contact: Clare Dolan
Toboroz
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07577856· 3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
NCT07577843· 3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
NCT07277231· 3. fázis· BeOne Medicines· Forrás
Contact: Study Director
Meghívásos bevonás
Optical Coherence Tomography in Acute Vessel Evaluation
NCT07422688· Aarhus University Hospital Skejby· Forrás
Fut, nem toboroz
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
NCT07196748· 3. fázis· Janssen Research & Development, LLC· Forrás
Még nem toboroz
Transcriptional Analysis of Mechanisms in Liver Failure and Sepsis
NCT07131969· University of Cambridge· Forrás
Contact: Mark McPhail
Toboroz
A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy
NCT06979375· 2. fázis· Novo Nordisk A/S· Forrás
Contact: Novo Nordisk
Toboroz
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459· 3. fázis· Amgen· Forrás
Toboroz
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
NCT06943872· 3. fázis· BeOne Medicines· Forrás
Contact: Study Director
Toboroz
PASS of Xromi Comparing Safety and Effectiveness in Children Under 2 Years With Sickle Cell Disease [PRECISE PASS]
NCT06923111· Nova Laboratories Limited· Forrás
Contact: Hussain Mulla, PhD
Toboroz
Anti-vascular Endothelial Growth Factor (Anti-VEGF) Monotherapy vs Anti-VEGF Followed by Subthreshold Micropulse Laser for Treating Severe Diabetic Macular Oedema When the Central Retina Goes <400 Microns
NCT06985706· 3. fázis· Belfast Health and Social Care Trust· Forrás
Contact: Mary Guiney
Toboroz
The Dragon PLC Trial (DRAGON-PLC)
NCT06914648· Maastricht University· Forrás
Contact: K. Menon, Dr. (principal investigator)
Toboroz
Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation
NCT06465953· 3. fázis· Institut de Recherches Internationales Servier· Forrás
Contact: Institut de Recherches Internationales Servier (I.R.I.S.), Clinical Studies Department
Fut, nem toboroz
A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease
NCT06544616· 2. fázis· Janssen Pharmaceutica N.V., Belgium· Forrás
Fut, nem toboroz
A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis
NCT06294925· Pfizer· Forrás
Fut, nem toboroz
A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide
NCT06208150· 3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
Post-Market Clinical Follow Up Study With Navitor Valve
NCT06008080· Abbott Medical Devices· Forrás
Contact: Philip MacCarthy
Fut, nem toboroz
Avacostar - (PASS)
NCT05897684· Vifor Fresenius Medical Care Renal Pharma· Forrás
Fut, nem toboroz
Sedation, Temperature and Pressure After Cardiac Arrest and Resuscitation
NCT05564754· Region Skane· Forrás
Fut, nem toboroz
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
NCT05797610· 3. fázis· Hoffmann-La Roche· Forrás
Toboroz
Observational SIR-Spheres Study for the Treatment of Unresectable Liver Tumors (SIRtain Registry)
NCT05967143· Sirtex Medical· Forrás
Contact: Paul Ross (principal investigator)
Fut, nem toboroz
Closed-loop for People Living With Cystic Fibrosis Related Diabetes
NCT05562492· University of Cambridge· Forrás
Toboroz
The SMARTER Cardiomyopathy Study
NCT05750147· Imperial College London· Forrás
Contact: Study Coordinator
Fut, nem toboroz
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
NCT05702034· 3. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
NCT05476926· Hoffmann-La Roche· Forrás
Fut, nem toboroz
A Study of Tebapivat (AG-946) in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS)
NCT05490446· 2. fázis· Agios Pharmaceuticals, Inc.· Forrás
Fut, nem toboroz
RadiothErapy priMIng for CAR-T
NCT04726787· University College, London· Forrás
Toboroz
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
NCT04779320· 3. fázis· Takeda· Forrás
Contact: Babu Vadamalayan (principal investigator)
Fut, nem toboroz
A Study of Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory Multiple Myeloma
NCT05160584· Janssen Pharmaceutica N.V., Belgium· Forrás
Fut, nem toboroz
Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia
NCT04994717· 3. fázis· Amgen· Forrás
Fut, nem toboroz
A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma
NCT05083169· 3. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy
NCT04923893· 3. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
A Study of the Efficacy, Safety, and Pharmacokinetics of a 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome)
NCT04657289· 3. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation
NCT04788888· Abbott Medical Devices· Forrás
Fut, nem toboroz
Prospective Observational Study of Filgotinib in Subjects With Rheumatoid Arthritis
NCT04871919· Alfasigma S.p.A.· Forrás
Fut, nem toboroz
A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease
NCT04777331· 2. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
A Study Evaluating the Efficacy and Safety of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement Inhibitors
NCT04434092· 3. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants With Relapsed and Lenalidomide-Refractory Multiple Myeloma
NCT04181827· 3. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies
NCT03888105· 2. fázis· Regeneron Pharmaceuticals· Forrás
Fut, nem toboroz
A Comparison of Reduced Dose Total Body Irradiation (TBI) and Cyclophosphamide With Fludarabine and Melphalan Reduced Intensity Conditioning in Adults With Acute Lymphoblastic Leukaemia (ALL) in Complete Remission. (ALL-RIC)
NCT03821610· 2. fázis· University of Birmingham· Forrás
Toboroz
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
NCT03435796· 2/3. fázis· Celgene· Forrás
Contact: Reuben BEnjamin, Site 10851
Toboroz
The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd)
NCT03562169· 3. fázis· University of Leeds· Forrás
Contact: Majid Kazmi
Fut, nem toboroz
Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients
NCT03049189· 3. fázis· ITM Solucin GmbH· Forrás